Ex-Valeant executive, ex-pharmacy CEO charged for fraud scheme

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. SMCI
6. GOOGL
7. RTX
8. COF
9. TSLA
10. BRZE

Go back to Ex-Valeant executive, ex-pharmacy CEO charged for fraud scheme

Additional Charges Against Valeant Pharma (VRX) or Former Execs Cannot Be Ruled Out - Wells Fargo's Maris

November 17, 2016 1:46 PM EST

Wells Fargo analyst David Maris weighed in on Valeant Pharma (NYSE: VRX) after today's DOJ press conference. Maris said based on the comments additional charges against Valeant or former Valeant executives cannot be ruled out,

Maris commented, "Earlier in the day, a Valeant... More

Valeant Pharma (VRX) Off Lows as Charges Relate to Employee Fraud Versus Company Fraud

November 17, 2016 11:45 AM EST

Valeant Pharma (NYSE: VRX) is bouncing off morning lows as the charges against former exec Gary Tanner and CEO the Philidor Andrew Davenport appear more related to individual fraud versus company fraud. Shares of VRX are down 2% after trading down 7%... More

Valeant Pharma (VRX) Comments on Philidor Criminal Complaint; Says Co., Former CEO/CFO Not Yet Charged

November 17, 2016 10:48 AM EST

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) learned that a criminal complaint was filed in relation to Philidor. Gary Tanner and Andrew Davenport were charged in the matter. The company, former CEO, former CFO, and current executives have not been charged at this... More